switching between glp 1 agonists chart Glucagon-like peptide-1 receptor and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study GLP-1 Agonists - What is

Improved imputation accuracy of rare and low-frequency variants using population-specific high-coverage WGS-based imputation reference panel

Cardiac metabolism in hfpef: from fuel to signalling

Metabolisms 52(7):908915

Gastrointestinal hormones and the dialogue between gut and brain

This process involves starting with a lower dose and gradually increasing it over several weeks or months until the target therapeutic dose is reached

(2015) discovered that exendin-4 treatment in Glp1r+/+ mice elevated cAMP levels in isolated intraepithelial lymphocytes while reducing the transcription of multiple inflammatory mediators, including IL-1, IL-6, IL-22, IL-12, TNF-, CCL2, CXCL1, and CXCL2